CYSTIALIZ Feline & Canine Urinary Support Oral Liquid (60 ml)
Bladder Mucosal Barrier, Bacterial Adhesion and Urine Composition Supporting Liquid
CYSTIALIZ Liposomal Urinary Support is an ultra-premium veterinary formulation developed to protect lower urinary tract health and bladder mucosal barrier at the cellular level in cats and dogs. It supports clinical protocols as a cofactor during idiopathic cystitis (FIC) attack periods, urinary discomforts, bacterial cystitis prophylaxis, and sensitive periods following surgical interventions. Thanks to its rich ingredient profile, it helps balance urine composition and strengthen the bladder wall against environmental stress factors.
Manufactured with liposomal technology in Zoopa-licensed GMP and ISO standard facilities, the formula ensures active ingredients reach target tissues with maximum bioavailability. The synergy of N-acetyl-D-glucosamine, A-type proanthocyanidins, D-Mannose, and Quercetin contributes to the repair of the urinary tract mucosa, prevention of bacterial adhesion, and balancing of oxidative load. It is an ideal adjuvant safely prescribed by expert veterinarians in clinical cases.
Targeted Physiological Axes
The three essential physiological axes targeted and optimized at the cellular level by this formula
Idiopathic Cystitis (FIC) Management
Enhances bladder comfort during and between FIC episodes, helping to reduce symptoms like periuria and pollakiuria.
Post-Urethral Obstruction Recovery
Supports mucosal healing following catheter removal and helps reduce the risk of recurrence.
Prophylaxis for Recurrent Bacterial Cystitis
Aids in preventing recurrence of urinary tract infections, either as an adjunct to culture-based antibiotic treatment or during maintenance periods.
Key Active Botanical & Bio-Actives
Pharmaceutical-grade bio-active constituents and their therapeutic roles
N-asetil-D-glukozamin (NAG)
250 mgServes as the building block of the glycosaminoglycan (GAG) layer lining the urothelium.
Kızılcık Özü
150 mgPrevents uropathogenic bacteria from adhering to the bladder epithelium via A-type proanthocyanidins.
D-Mannoz
200 mgBinds to Type 1 fimbriae, ensuring bacteria are mechanically cleared through urine.
Kuersetin
100 mgStabilizes mast cells and suppresses histamine release, protecting the bladder wall.
Hiyalüronik Asit
50 mgStrengthens the mucosal barrier by supporting the structure of the GAG layer.
Clinical & Biochemical Rationale
Chosen Family CYSTIALIZ targets the lower urinary system by supporting the bladder mucosal barrier, preventing bacterial adhesion, and modulating urine composition. Key ingredients like N-acetyl-D-glucosamine (NAG), Cranberry extract, and D-Mannose work synergistically to protect the urothelium, inhibit bacterial attachment to the bladder wall, and facilitate their mechanical removal. Quercetin and Hyaluronic acid further contribute to mucosal integrity and anti-inflammatory effects. This liposomal formulation ensures enhanced bioavailability of its active components, providing comprehensive cellular antioxidant support and promoting overall urinary tract health.
Veterinary Administration Standard
Recommended Dosage & Administration Protocol
View Protocol
Hide
Recommended Dosage & Administration Protocol
- 01 Administer orally or mix into food according to the weight of the animal. For cats and dogs up to 5 kg, give 0.5-1 ml daily; for 10 kg, give 1-2 ml daily; for 30 kg, give 3-6 ml daily. Ensure fresh drinking water is always available alongside the administration.
Frequently Asked Questions
Essential clinical questions on formula kinetics, tolerance, and administration
How does CYSTIALIZ Feline & Canine Urinary Support Oral Liquid (60 ml) reduce nephron workload in chronic kidney disease patients?
CYSTIALIZ Feline & Canine Urinary Support Oral Liquid (60 ml) binds enteric phosphorus and uremic waste, preventing systemic reabsorption and alleviating hyperfiltration stress on remaining functional nephrons.
When can stabilization in serum BUN, Creatinine, and SDMA levels be expected?
Clinical stabilization in serum uremic markers is officially verified through follow-up biochemistry panels at day 30 and day 60 of continuous therapy.
Can CYSTIALIZ Feline & Canine Urinary Support Oral Liquid (60 ml) be administered alongside renal prescription diets and ACE inhibitors?
Yes, it exhibits complete synergistic compatibility with veterinary-prescribed renal diets and cardiovascular medications without pharmacokinetic competition.
Should CYSTIALIZ Feline & Canine Urinary Support Oral Liquid (60 ml) be given on an empty stomach or with meals?
To maximize phosphate-binding efficacy in the intestinal lumen, administration with meals or blended directly into daily food is clinically recommended.
How does CYSTIALIZ Feline & Canine Urinary Support Oral Liquid (60 ml) address uremic inappetence and weight loss?
By mitigating circulating uremic waste, it relieves uremic gastritis and nausea, supporting spontaneous appetite and lean body mass retention.
Where can you obtain Chosen Family formulas?
Our formulations are distributed exclusively through authorized veterinary hospitals and clinical practices to accompany veterinary care.
